Clinical Characterization and Molecular Analysis of Fourteen Chinese Patients with Factor V Deficiency

Abstract

Introduction Coagulation factor V (FV) functions as a vital cofactor that performs procoagulant roles in the coagulation system. We investigated 14 unrelated patients whose plasma FV levels were all below the reference range.

Methods FV activity (FV:C) and FV antigen were detected by one-stage clotting and ELISA, respectively. All 25 exons of the F5 gene in patients were amplified by the PCR, and they were sequenced directly. Haplotype analysis was performed with different polymorphisms on F5. Protein modeling was applied to analyze the potential molecular mechanisms.

Results Of five patients with higher FV levels (FV:C > 10%), only one had minor bleeding symptoms. In contrast, of the remaining eight patients with lower FV levels (FV:C < 10%), six showed various bleeding manifestations. A total of 10 mutations were detected from 14 patients (6 were novel mutations). Interestingly, the homozygous p.Phe190Ser was found in five pedigrees, and haplotype analysis showed that they shared almost the same haplotype, indicating the common origin rather than a hotspot mutation. In silico analysis preliminarily investigated the potential pathogenic mechanism of the mutation. Modeling analysis showed that all six missense mutations would lead to conformational alterations in the FV protein. Among them, three (p.Gly1715Ser, p.Ser1753Arg, and p.Asp68His) would decrease hydrogen bonds.

Conclusion This is the largest genetic analysis of a single cohort of FV deficiency in Chinese. The study demonstrated that FV levels tended to be correlated with the probability of hemorrhage. The identification of a large number of unique FV-deficient pedigrees highlighted the screening for mutations in F5.

Keywords

factor V deficiency - sequencing - mutation profile - haplotype - hemorrhage

Statement of Ethics

Our study was approved by the Ethics Committee in Clinical Research (ECCR) of the First Affiliated Hospital of Wenzhou Medical University (number: KY2022-R193). All participants signed the written informed consent.

Data Availability Statement

The data that support the conclusions of this study are available from the corresponding author upon request. Further inquiries can be directed to the corresponding author.

Publication History

Received: 23 May 2023

Accepted: 02 August 2023

Article published online:
15 September 2023

• References

• 1 Petrillo T, Ayombil F, Van't Veer C, Camire RM. Regulation of factor V and factor V-short by TFPIα: relationship between B-domain proteolysis and binding. J Biol Chem 2021; 296: 100234
• 2 Dahlbäck B. Advances in understanding mechanisms of thrombophilic disorders. Hamostaseologie 2020; 40 (01) 12-21
• 3 Castoldi E, Hézard N, Mourey G. et al. Severe thrombophilia in a factor V-deficient patient homozygous for the Ala2086Asp mutation (FV Besançon). J Thromb Haemost 2021; 19 (05) 1186-1199
• 4 Tabibian S, Shiravand Y, Shams M. et al. A comprehensive overview of coagulation factor V and congenital factor V deficiency. Semin Thromb Hemost 2019; 45 (05) 523-543
• 5 Nakayama D, Ben Ammar Y, Miyata T, Takeda S. Structural basis of coagulation factor V recognition for cleavage by RVV-V. FEBS Lett 2011; 585 (19) 3020-3025
• 6 Schreuder M, Reitsma PH, Bos MHA. Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding. J Thromb Haemost 2019; 17 (08) 1229-1239
• 7 Dahlbäck B. Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S. J Thromb Haemost 2017; 15 (07) 1241-1250
• 8 Ruben EA, Rau MJ, Fitzpatrick JAJ, Di Cera E. Cryo-EM structures of human coagulation factors V and Va. Blood 2021; 137 (22) 3137-3144
• 9 Deng J, Li D, Mei H, Tang L, Wang HF, Hu Y. Combined deficiency of factors V and VIII in a Chinese family due to a novel nonsense mutation in lectin mannose binding protein 1. Int J Lab Hematol 2020; 42 (01) e7-e9
• 10 Owren PA. Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet 1947; 1 (6449) 446-448
• 11 Asselta R, Peyvandi F, Factor V. Factor V deficiency. Semin Thromb Hemost 2009; 35 (04) 382-389
• 12 Naderi M, Tabibian S, Alizadeh S. et al. Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders. Acta Haematol 2015; 133 (02) 148-154
• 13 Rodeghiero F, Tosetto A, Abshire T. et al; ISTH/SSC Joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 8 (09) 2063-2065
• 14 Luo S, Liu S, Xu M. et al. Analysis of phenotype and genotype of a family with hereditary coagulation factor V deficiency caused by the compound heterozygous mutations. Blood Coagul Fibrinolysis 2020; 31 (07) 485-489
• 15 Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 2014; 12 (11) 1935-1939
• 16 Thalji N, Camire RM. Parahemophilia: new insights into factor V deficiency. Semin Thromb Hemost 2013; 39 (06) 607-612
• 17 Duckers C, Simioni P, Spiezia L. et al. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood 2010; 115 (04) 879-886
• 18 Dong R, Chen G, Jin Y, Wang M, Cheng X, Chen Y. Significance of the p.Phe218Ser and p.Gly304Glu F5 variants in hereditary factor V deficiency. Acta Haematol 2021; 144 (06) 712-716
• 19 Kanaji S, Kanaji T, Honda M. et al. Identification of four novel mutations in F5 associated with congenital factor V deficiency. Int J Hematol 2009; 89 (01) 71-75